Blutzuckermodulierende Polypeptide
European patent · EP2191837 · In force
Register entry
- Publication number
- EP2191837
- Application number
- EP09154406
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Mar 5, 2009
- Published
- Jun 2, 2010
- Granted
- May 7, 2014
- Protection ends at the latest
- Mar 4, 2029
- Next annual fee due
- Mar 31, 2027
- IPC classes
- A61K 38/04 (2006.01)A61P 3/08 (2006.01)A61K 38/16 (2006.01)
- Priority
- TW 97146586 01.12.2008
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.03.2026 → 31.03.2027
Published in Swissreg on 01.07.2026
- Jul 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.03.2025 → 31.03.2026
Published in Swissreg on 01.07.2025
- Apr 8, 2024
Change
Published in Swissreg on 08.04.2024
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- Nov 15, 2016
Address changed
- Representative
- LangPatent Anwaltskanzlei, Zürcherstrasse 161, 8010 Zürich → LangPatent Anwaltskanzlei IP Law Firm, c/o Christian Lang, Täätschestrasse 38, Postfach 454, 3914 Blatten b. Naters
Published in Swissreg on 15.11.2016
- May 7, 2014
Granted
Published in Swissreg on 07.05.2014
- May 7, 2014
Agent entered
- Representative
- LangPatent Anwaltskanzlei, Zürcherstrasse 161, 8010 Zürich
Published in Swissreg on 07.05.2014
Parties
Inventor
Ho, Tin-Yun
40402, Taichung, TW
Hsiang, Chien-Yun
40402, Taichung, TW
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.